Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells

被引：28

作者：

Chen, Ming-Cheng ^{[1
,2
]}

Lee, Nien-Hung ^{[1
]}

Ho, Tsung-Jung ^{[3
]}

Hsu, Hsi-Hsien ^{[4
,5
]}

Kuo, Chia-Hua ^{[6
]}

Kuo, Wei-Wen ^{[7
]}

Lin, Yueh-Min ^{[8
,9
]}

Tsai, Fuu-Jen ^{[10
]}

Tsai, Chang-Hai ^{[11
]}

Huang, Chih-Yang ^{[1
,10
,12
]}

机构：

[1] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan

[2] Taichung Vet Gen Hosp, Puli Branch, Nantou, Taiwan

[3] China Med Univ, Beigang Hosp, Chinese Med Dept, Yunlin, Taiwan

[4] Mackay Mem Hosp, Div Colorectal Surg, Taipei, Taiwan

[5] Nursing & Management Coll, Mackay Jr Coll Med, Taipei, Taiwan

[6] Univ Taipei, Dept Sports Sci, Taipei, Taiwan

[7] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan

[8] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan

[9] Jen Teh Jr Coll Med, Dept Med Technol, Miaoli, Taiwan

[10] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan

[11] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan

[12] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan

来源：

CANCER LETTERS | 2014年 / 349卷 / 01期

关键词：

Chemoresistance; CPT-11; NF-kappa B; Metastasis; Autophagy; COLORECTAL-CANCER; INDUCIBLE CHEMORESISTANCE; ANTICANCER DRUGS; GEFITINIB IRESSA; INHIBITION; CHEMOTHERAPY; MECHANISMS; THERAPY; DEATH; 5-FLUOROURACIL;

D O I：

10.1016/j.canlet.2014.03.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chemotherapy is usually applied to treat colon cancer but leads to chemoresistance, and increased metastasis and invasion. The main focus of this study is to observe effects of resistance to irinotecan (CPT-11) on metastasis, invasion and autophagy in CPT-11 resistant (CPT-11-R) LoVo colon cancer cells. CPT-11, a topoisomerase I inhibitor and a first-line chemotherapeutic drug, is used to treat colon cancer. CPT-11-R cells were constructed in a step-wise fashion with increasing CPT-11 doses. The CPT-11-R strain had a significantly lower expression of Wnt/beta-catenin pathway, but induced an EGFR/IKK alpha/beta/NF-kappa B pathway with elevated cell cycle, metastasis and basal autophagy. C) 2014 Elsevier Ireland Ltd. All rights reserved.

引用

页码：51 / 60

页数：10

共 50 条

[41] MicroRNA-133 inhibits the growth and metastasis of the human lung cancer cells by targeting epidermal growth factor receptor
Liu, Shuyuan
Chen, Jiachang
Zhang, Tianhai
Chen, Huayun
JOURNAL OF BUON, 2019, 24 (03): : 929 - 935
[42] Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells
Nie, Lei
Wang, Ying-Nai
Hsu, Jung-Mao
Hou, Junwei
Chu, Yu-Yi
Chan, Li-Chuan
Huo, Longfei
Wei, Yongkun
Deng, Rong
Tang, Jun
Hsu, Yi-Hsin
Ko, How-Wen
Lim, Seung-Oe
Huang, Kebin
Chen, Mei-Kuang
Chiu, Tai-Jan
Cheng, Chien-Chia
Fang, Yueh-Fu
Li, Chia-Wei
Goverdhan, Aarthi
Wu, Hsing-Ju
Lee, Cheng-Chung
Wang, Wen-Ling
Hsu, Jennifer
Chiao, Paul
Wang, Shao-Chun
Hung, Mien-Chi
AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (04): : 1209 - +
[43] Divalent lead cations induce cyclooxygenase-2 gene expression by epidermal growth factor receptor/nuclear factor-kappa B signaling in A431 carcinoma cells
Chou, Yii-Her
Woon, Peng-Yeong
Huang, Wan-Chen
Shiurba, Robert
Tsai, Yao-Ting
Wang, Yu-Shiuan
Hsieh, Tusty-Jiuan
Chang, Wen-Chang
Chuang, Hung-Yi
Chang, Wei-Chiao
TOXICOLOGY LETTERS, 2011, 203 (02) : 147 - 153
[44] Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells
Eckstein, Niels
Servan, Kati
Girard, Luc
Cai, Di
von Jonquieres, Georg
Jaehde, Ulrich
Kassack, Matthias U.
Gazdar, Adi F.
Minna, John D.
Royer, Hans-Dieter
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (02) : 739 - 750
[45] Mesalazine disrupts epidermal growth factor receptor (EGFR) signaling by promoting phosphatase activity in colon cancer cells
Fina, D
Vavassori, P
Franchi, L
Caruso, R
Visconti, E
Naccari, GC
Andrei, F
Testi, R
Pallone, F
Monteleone, G
GASTROENTEROLOGY, 2005, 128 (04) : A479 - A479
[46] Growth inhibition of human colon cancer cells by sodium butyrate and epidermal growth factor receptor (EGFR) related protein (ERRP).
Reddy, S
Rishi, AK
Majumdar, AP
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9046S - 9046S
[47] MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
Huang, Ming-Hung
Lee, Jih-Hsiang
Chang, Ya-Ju
Tsai, Hsin-Hui
Lin, Yu-Lin
Lin, Anya Maan-Yuh
Yang, James Chih-Hsin
MOLECULAR ONCOLOGY, 2013, 7 (01) : 112 - 120
[48] Investigation of two dosing schedules of vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, in combination with irinotecan in a human colon cancer xenograft model
Troiani, Teresa
Serkova, Natalie J.
Gustafson, Daniel L.
Henthorn, Thomas K.
Lockerbie, Owen
Merz, Andrea
Long, Michael
Morrow, Mark
Ciardiello, Fortunato
Eckhardt, S. Gail
CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6450 - 6458
[49] Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
Coffey, RJ
Hawkey, CJ
Damstrup, L
GravesDeal, R
Daniel, VC
Dempsey, PJ
Chinery, R
Kirkland, SC
DuBois, RN
Jetton, TL
Morrow, JD
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) : 657 - 662
[50] Magnetic lipid-poly(lactic-co-glycolic acid) nanoparticles conjugated with epidermal growth factor receptor antibody for dual-targeted delivery of CPT-11
Shivanna, Anilkumar T.
Dash, Banendu Sunder
Lu, Yu-Jen
Lin, Wei-Ting
Chen, Jyh-Ping
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 667

← 1 2 3 4 5 →